X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AJANTA PHARMA with Fulford India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs FULFORD INDIA - Comparison Results

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA FULFORD INDIA AJANTA PHARMA/
FULFORD INDIA
 
P/E (TTM) x 20.4 398.8 5.1% View Chart
P/BV x 8.8 6.2 142.2% View Chart
Dividend Yield % 0.7 0.1 802.0%  

Financials

 AJANTA PHARMA   FULFORD INDIA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-16
FULFORD INDIA
Mar-14
AJANTA PHARMA/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs1,720942 182.6%   
Low Rs1,103450 245.1%   
Sales per share (Unadj.) Rs194.6691.4 28.1%  
Earnings per share (Unadj.) Rs45.211.5 394.5%  
Cash flow per share (Unadj.) Rs50.315.4 327.5%  
Dividends per share (Unadj.) Rs8.002.00 400.0%  
Dividend yield (eoy) %0.60.3 197.2%  
Book value per share (Unadj.) Rs132.0380.0 34.7%  
Shares outstanding (eoy) m88.773.90 2,276.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.31.0 720.5%   
Avg P/E ratio x31.260.7 51.4%  
P/CF ratio (eoy) x28.145.3 61.9%  
Price / Book Value ratio x10.71.8 583.7%  
Dividend payout %17.717.4 101.4%   
Avg Mkt Cap Rs m125,2992,714 4,616.1%   
No. of employees `000NA0.4 0.0%   
Total wages/salary Rs m2,570505 508.9%   
Avg. sales/employee Rs ThNM6,073.0-  
Avg. wages/employee Rs ThNM1,137.4-  
Avg. net profit/employee Rs ThNM100.7-  
INCOME DATA
Net Sales Rs m17,2752,696 640.7%  
Other income Rs m166125 132.6%   
Total revenues Rs m17,4422,822 618.1%   
Gross profit Rs m5,807-46 -12,515.5%  
Depreciation Rs m45115 2,964.5%   
Interest Rs m4910 514.7%   
Profit before tax Rs m5,47454 10,081.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,46010 15,207.3%   
Profit after tax Rs m4,01445 8,980.1%  
Gross profit margin %33.6-1.7 -1,953.5%  
Effective tax rate %26.717.7 150.9%   
Net profit margin %23.21.7 1,401.6%  
BALANCE SHEET DATA
Current assets Rs m7,6391,738 439.4%   
Current liabilities Rs m2,715545 498.4%   
Net working cap to sales %28.544.3 64.4%  
Current ratio x2.83.2 88.2%  
Inventory Days Days4348 89.2%  
Debtors Days Days794 1,827.6%  
Net fixed assets Rs m6,91412 58,099.2%   
Share capital Rs m17739 453.6%   
"Free" reserves Rs m11,4421,443 792.9%   
Net worth Rs m11,7211,482 790.9%   
Long term debt Rs m1490-   
Total assets Rs m14,8142,077 713.4%  
Interest coverage x112.96.7 1,681.7%   
Debt to equity ratio x00-  
Sales to assets ratio x1.21.3 89.8%   
Return on assets %27.42.6 1,050.8%  
Return on equity %34.23.0 1,135.5%  
Return on capital %46.54.3 1,080.9%  
Exports to sales %55.10-   
Imports to sales %6.024.5 24.6%   
Exports (fob) Rs m9,527NA-   
Imports (cif) Rs m1,038659 157.4%   
Fx inflow Rs m10,42217 60,591.9%   
Fx outflow Rs m1,678673 249.3%   
Net fx Rs m8,744-656 -1,332.9%   
CASH FLOW
From Operations Rs m3,26490 3,626.4%  
From Investments Rs m-2,093105 -2,000.9%  
From Financial Activity Rs m-1,186-14 8,409.2%  
Net Cashflow Rs m-15181 -8.2%  

Share Holding

Indian Promoters % 73.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 1.6 3.8 40.8%  
FIIs % 7.6 0.1 7,600.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 21.2 80.2%  
Shareholders   20,968 4,783 438.4%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   MERCK LTD  STERLING BIOTECH  TORRENT PHARMA  SUVEN LIFE  CIPLA  

Compare AJANTA PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Strong; Consumer Durables Stocks Drag(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are trading above the dotted line. Except stocks in the consumer durables sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Aug 23, 2017 01:54 PM

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS